Previous close | 165.81 |
Open | 168.40 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 167.40 - 169.00 |
52-week range | 123.00 - 192.20 |
Volume | |
Avg. volume | 8,670 |
Market cap | N/A |
Beta (5Y monthly) | 0.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 17 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Borregaard’s operating revenues were NOK 1,949 million (NOK 1,963 million)2 in the 2nd quarter of 2024. EBITDA1 was NOK 510 million (NOK 537 million). The result in BioSolutions increased while the result in BioMaterials was lower compared with the 2nd quarter of 2023. Fine Chemicals delivered a strong result slightly below the same quarter last year. Improved product mix and reduced energy costs were the main reasons for a strong result in BioSolutions. In BioMaterials, the result was affected
10 July 2024: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q2 2024 results Borregaard will report second quarter 2024 results on Wednesday 17 July 2024 at 07:00 CEST. A stock exchange announcement will be made. A press release, the quarterly report and a presentation will be made available on https://www.borregaard.com/investors/. A presentation of the second quarter 2024 results will also be held at 08:30 CEST and can be followed live on web-TV at https://www.borregaard.com/in
Today, primary insider Ole Gunnar Jakobsen, Plant Director, Sarpsborg Site, exercised 20,000 stock options at a strike price of NOK 87.60 per share, and in separate transactions, purchased and sold the same number of shares. The shares are drawn from Borregaard’s holdings of treasury shares. Please, see attached notifications for persons discharging managerial responsibilities in Borregaard in accordance with Regulation EU 596/2014 (MAR) article 19. After the transactions, Ole Gunnar Jakobsen ow